期刊文献+

恶性肿瘤患者静脉应用化疗药物外渗的原因分析及预防 被引量:5

The Reason Analysis and Prevention of Extravasation of Chemotherapy Drugs on Patients with Cancer
下载PDF
导出
摘要 目的探讨恶性肿瘤患者静脉应用化疗药物外渗的相关因素,并提出预防措施。方法对2008年1月至2010年1月收治的1214例恶性肿瘤患者静脉应用化疗药物的情况进行回顾性分析。结果 1214例患者静脉应用化疗药物时发生药物外渗45例,其中与护理方面有关22例,占48.89%;与药物方面有关15例,占33.33%;与患者自身有关8例,占17.78%。结论恶性肿瘤患者静脉应用化疗药物发生外渗的主要原因为护理因素,提出应加强护士风险防范意识及责任心的培养,加强护士业务技术的培训,同时不可忽视患者的健康教育等预防对策。 Objective: To figure out the reason of extravasation of chemotherapy drugs on patients with cancer and forward the prevention measures. Methods: 1214 patients with cancer who used chemotherapy drugs by vein were analyzed. Results: There were 45 patients of the 1214 patients with cancer got extravasafion of chemotherapy drugs. 22 patients (48.89%) who got the extravasation were because of the nursing issues, 15 patients (33.33%) were because of the drugs, and 8 patients (17.78%) were because of themselves. Conclusion: The major reason of the extravasation of chemotherapy drugs on patients with cancer was nursing issue. There were a few prevention measures, including enhance nurses' risk prevention, responsibility, and skills training. Health education was important as well.
出处 《当代护士(中旬刊)》 2011年第2期1-3,共3页 Modern Nurse
关键词 肿瘤 化疗药物 外渗 护理 预防 Cancer Chemotherapy drugs Extravasation Nursing Prevention
  • 相关文献

参考文献4

二级参考文献34

共引文献91

同被引文献59

  • 1杨翠芹,黄敏清,李良芳,林文梁,赵艳红,罗素芬,郭锡群.长春瑞滨外漏组织损伤后局部封闭的实验研究[J].护理学杂志,2005,20(2):3-5. 被引量:11
  • 2李秀芹,刘萍.化疗药物渗漏引起组织损伤的临床表现及护理[J].实用医技杂志,2005,12(06A):1512-1512. 被引量:1
  • 3毛文妹.安尔碘皮肤消毒剂应用于长春瑞滨静脉外渗的护理[J].护理研究(上旬版),2006,20(4):910-910. 被引量:3
  • 4陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919.
  • 5Gozzo Tde O,Panobianco MS,Clapis M J. Dermatological toxicity in women with breast cancer undergoingchemotherapy treatment[J].Rev Lat Am Enfermagem,2010,(04):681-687.
  • 6Schulmeister L. Managing vesicant extravasations[J].{H}Oncologist(the)t,2008,(03):284-288.
  • 7Schulmeister L. Preventing and Managing Vesicant Chemotherapy Extravasations[J].J Support Oncol,2010,(05):212-215.
  • 8Wengstr(o)m Y,Margulies A,European Oncology Nursing Society Task Force. European Oncology Nursing Society extravasation guidelines[J].Eur J Oncol Nurs,2008,(04):357-361.
  • 9Reeves D. Management of anthracline extravasation injuries[J].Ann Pharmaeother,2007,(07):1238-1242.
  • 10Muthuramalingam S,Gale J,Bradbury J. Dexrazoxane efficacy for anthracycline extravasation:use in UK clinical practice[J].{H}INTERNATIONAL Journal OF CLINICAL PRACTICE,2013,(03):244-249.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部